|
|
RAD51,CLONE:51RAD01(3C10),MABANTI-HUMAN,MOUSE,RAT:PARAFFIN,IH/WB/IP(NATIVE) |
RAD51,CLONE:51RAD01(3C10),MABANTI-HUMAN,MOUSE,RAT:PARAFFIN,IH/WB/IP(NATIVE) |
|
|
(5R)-1,4,5,7,8,9,10,11,11aβ,12-Decahydro-5α-(hydroxymethyl)-7-cyano-13-methyl-1,4-dioxo-2-amino-8β,11β-epiminoazepino[1,2-b]isoquinoline-10β-carboxylic acid |
(5R)-1,4,5,7,8,9,10,11,11aβ,12-Decahydro-5α-(hydroxymethyl)-7-cyano-13-methyl-1,4-dioxo-2-amino-8β,11β-epiminoazepino[1,2-b]isoquinoline-10β-carboxylic acid |
|
|
[1R,4aα,(-)]-Decahydro-1-(5-hydroxy-3-methyl-3-pentenyl)-2,5,5,8aα-tetramethylnaphthalene-2β-ol |
[1R,4aα,(-)]-Decahydro-1-(5-hydroxy-3-methyl-3-pentenyl)-2,5,5,8aα-tetramethylnaphthalene-2β-ol |
|
|
(5R)-1,4,5,7,8,9,10,11,11aβ,12-Decahydro-5α-(hydroxymethyl)-7-cyano-13-methyl-1,4-dioxo-2-(methylthio)-3-(methylthio)-8β,11β-epiminoazepino[1,2-b]isoquinoline-10β-carboxylic acid |
(5R)-1,4,5,7,8,9,10,11,11aβ,12-Decahydro-5α-(hydroxymethyl)-7-cyano-13-methyl-1,4-dioxo-2-(methylthio)-3-(methylthio)-8β,11β-epiminoazepino[1,2-b]isoquinoline-10β-carboxylic acid |
|
|
(1R,4aα)-Decahydro-2,5,5,8aβ-tetramethyl-1-[(1E,3E)-3-methyl-1,3-pentadienyl]naphthalen-2α-ol |
(1R,4aα)-Decahydro-2,5,5,8aβ-tetramethyl-1-[(1E,3E)-3-methyl-1,3-pentadienyl]naphthalen-2α-ol |
|
|
|